TY  - GEN
AU  - Yang,T-S
AU  - Lu,S-N
AU  - Chao,Y
AU  - Sheen,I-S
AU  - Lin,C-C
AU  - Wang,T-E
AU  - Chen,S-C
AU  - Wang,J-H
AU  - Liao,L-Y
AU  - Thomson,J A
AU  - Wang-Peng,J
AU  - Chen,P-J
AU  - Chen,L-T
TI  - A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
SN  - 1532-1827
PY  - 2010///1025
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Arginine
KW  - blood
KW  - Asian People
KW  - Carcinoma, Hepatocellular
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Hydrolases
KW  - Liver Neoplasms
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - Retreatment
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.bjc.6605856
ER  -